Anti-glaucoma compositions
Patent 5182102 Issued on January 26, 1993. Estimated Expiration Date: 
July 12, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
July 12, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMicroporous-semipermeable laminated osmotic system Sustained release, comfort formulation for glaucoma therapy Patent #: 4911920 InventorsApplicationNo. 728920 filed on 07/12/1991US Classes:424/78.1, Ion exchange resin424/78.18, Polymer derived from ethylenic monomers only424/427, Ocular424/428, Bioerrodable, resorbable, or dissolving424/486, Synthetic polymer424/487, Acrylic acid and derivatives424/501, Contains solid synthetic resin514/772.6, Carboxylic acid containing monomer514/913GlaucomaExaminersPrimary: Michl, Paul R.Assistant: Webman, E. J. Attorney, Agent or FirmInternational ClassesA61K 009/10A61K 047/32 A61K 031/135 A61K 031/14 AbstractOphthalmic pharmaceutical compositions useful in controlling elevated intraocular pressure associated with glaucoma and ocular hypertension are described. The compositions comprise a combination of a beta-blocker to reduce the production of aqueous humor and carbachol to enhance the outflow of aqueous humor. A method of controlling elevated intraocular pressure with those compositions is also described.Other References
| |
